Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical Correlates of Longitudinal PET Changes in Alzheimer's Disease (AD)
Authors not listed
National Institute on Aging (NIA) · 2004
Abstract
The purpose of this study is to identify the earliest predictors of memory and brain deterioration in pre-clinical Alzheimer's disease using positron emission tomography (PET) to monitor brain glucose metabolism.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-30 MST
Cite this
APA
Anonymous. (2004). Clinical Correlates of Longitudinal PET Changes in Alzheimer's Disease (AD). <em>National Institute on Aging (NIA)</em>. https://clinicaltrials.gov/study/NCT00094913
Vancouver
Anonymous. Clinical Correlates of Longitudinal PET Changes in Alzheimer's Disease (AD). National Institute on Aging (NIA). 2004.
BibTeX
@misc{anon2004Clinic,
title = {Clinical Correlates of Longitudinal PET Changes in Alzheimer's Disease (AD)},
author = {Anonymous},
journal = {National Institute on Aging (NIA)},
year = {2004},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Colorado, Denver 2016
Open access · US-GOV
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment
Neurobiology of Disease 2014
Preprint · OA
Early detection of Alzheimer's disease using PiB and FDG PET
Judit Pich Martínez 2015
Open access · US-GOV
Study of Genetic Alzheimer's Disease Mutation Carriers in Preclinical Stages of the Disease: 18F-Florbetaben Positron Emission Tomography Study
Amsterdam UMC, location VUmc 2001
Open access · US-GOV
The Distribution and Quantification of Specific Binding of the Positron Emission Tomography Tracer R)-[11C]PK11195 in Normal Human Subjects
University of California, Los Angeles 2000
Open access · US-GOV
Anti-Inflammation in AD: PET Imaging Supplement
Acta Neuropathologica 2003
Citation only